
Inovio Pharmaceuticals, Inc.
INOHealthcare|Biotechnology|US
$1.22
-0.23 (-16.21%)
DCF Value
$0.69
Tangible Book / Share
$0.05
Cash / Share
$0.45
Ownership Breakdown
118.5%
Float
69.1M
Shares Outstanding
81.9M
Float Shares
Major Holders (26)
Combined: 165.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMR LLC | Holding company | 14.50% | 15,364,105 | Nov 5, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 14.50% | 15,364,105 | Nov 5, 2026 | 13D/G |
| Janus Henderson Group PLC | IA, HC | 9.99% | 6,666,295 | Dec 8, 2025 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 10,666,523 | Aug 7, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 10,666,523 | Aug 7, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 10,666,523 | Aug 7, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 10,666,523 | Aug 7, 2026 | 13D/G |
| Highbridge Capital Management, LLC | IA, OO | 9.20% | 3,633,333 | Feb 10, 2025 | 13D/G |
| Highbridge Capital Management LLC | IA, OO | 8.20% | 6,190,475 | May 15, 2026 | 13D/G |
| Alyeska Investment Group, L.P. | Investment adviser | 5.99% | 4,000,000 | Feb 17, 2026 | 13D/G |
| Alyeska Fund GP, LLC | Other | 5.99% | 4,000,000 | Feb 17, 2026 | 13D/G |
| Anand Parekh | Individual | 5.99% | 4,000,000 | Feb 17, 2026 | 13D/G |
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 5.30% | 2,802,530 | Nov 14, 2025 | 13D/G |
| Vanguard Capital Management | Investment adviser | 5.05% | 4,161,566 | Jul 31, 2026 | 13D/G |
| The Vanguard Group | Investment adviser | 4.96% | 3,315,579 | Jan 30, 2026 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 4.00% | 3,428,571 | Aug 12, 2026 | 13D/G |
| Phillip Gross | HC, IN | 4.00% | 3,428,571 | Aug 12, 2026 | 13D/G |
| Robert Atchinson | HC, IN | 4.00% | 3,428,571 | Aug 12, 2026 | 13D/G |
| Stonepine Capital Management, LLC | IA, OO | 3.80% | 1,434,997 | May 14, 2025 | 13D/G |
| Jon M. Plexico | HC, IN | 3.80% | 1,434,997 | May 14, 2025 | 13D/G |
| Stonepine GP, LLC | Other | 3.80% | 1,434,997 | May 14, 2025 | 13D/G |
| Stonepine Capital, L.P. | Partnership | 3.80% | 1,434,997 | May 14, 2025 | 13D/G |
| Deep Track Capital, LP | IA, OO | 2.41% | 1,314,796 | Nov 14, 2025 | 13D/G |
| David Kroin | HC, IN | 2.41% | 1,314,796 | Nov 14, 2025 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 2.41% | 1,314,796 | Nov 14, 2025 | 13D/G |
| BlackRock, Inc. | Holding company | 1.50% | 537,627 | Jul 17, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,344,587 acquired · 392,923 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| YARNO WENDY L | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| YARNO WENDY L | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| Shepard Jay | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| Shepard Jay | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| Miller Ann Calby | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| Miller Ann Calby | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| Weiner David B. | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| Weiner David B. | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| Zoth Lota S. | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| Zoth Lota S. | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| DANSEY ROGER D | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| DANSEY ROGER D | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| BENITO SIMON X | director | May 20, 2026 | AWARD | 41,800 | $1.23 | $51.4K | Form 4 |
| BENITO SIMON X | director | May 20, 2026 | AWARD | 34,200 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2026 | OPTION EX. | 6,027 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2026 | TAX W/H | 2,163 | $1.23 | $2.7K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2026 | AWARD | 34,160 | $1.73 | $59.1K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2026 | AWARD | 27,440 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2026 | OPTION EX. | 6,027 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 20, 2026 | AWARD | 46,876 | $1.73 | $81.1K | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 20, 2026 | OPTION EX. | 9,450 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 20, 2026 | TAX W/H | 2,693 | $1.23 | $3.3K | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 20, 2026 | AWARD | 37,684 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 20, 2026 | OPTION EX. | 9,450 | — | — | Form 4 |
| KIES PETER | CFO | May 20, 2026 | OPTION EX. | 8,700 | — | — | Form 4 |
| KIES PETER | CFO | May 20, 2026 | TAX W/H | 4,688 | $1.23 | $5.8K | Form 4 |
| KIES PETER | CFO | May 20, 2026 | AWARD | 39,760 | $1.73 | $68.8K | Form 4 |
| KIES PETER | CFO | May 20, 2026 | AWARD | 32,480 | — | — | Form 4 |
| KIES PETER | CFO | May 20, 2026 | OPTION EX. | 8,700 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2026 | AWARD | 123,760 | $1.73 | $214.1K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2026 | OPTION EX. | 28,296 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2026 | TAX W/H | 12,306 | $1.23 | $15.1K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2026 | AWARD | 100,240 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2026 | OPTION EX. | 28,296 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 15, 2026 | OPTION EX. | 17,744 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 15, 2026 | TAX W/H | 7,717 | $1.30 | $10.0K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 15, 2026 | OPTION EX. | 17,744 | — | — | Form 4 |
| KIES PETER | CFO | May 15, 2026 | OPTION EX. | 4,771 | — | — | Form 4 |
| KIES PETER | CFO | May 15, 2026 | TAX W/H | 2,571 | $1.30 | $3.3K | Form 4 |
| KIES PETER | CFO | May 15, 2026 | OPTION EX. | 4,771 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 15, 2026 | OPTION EX. | 4,771 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 15, 2026 | TAX W/H | 1,712 | $1.30 | $2.2K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 15, 2026 | OPTION EX. | 4,771 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 15, 2026 | OPTION EX. | 2,385 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 15, 2026 | TAX W/H | 680 | $1.30 | $884.00 | Form 4 |
| Sumner Michael John | Chief Medical Officer | May 15, 2026 | OPTION EX. | 2,385 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Mar 31, 2026 | OPTION EX. | 4,292 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Mar 31, 2026 | TAX W/H | 1,223 | $1.74 | $2.1K | Form 4 |
| Sumner Michael John | Chief Medical Officer | Mar 31, 2026 | OPTION EX. | 4,292 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Mar 4, 2026 | AWARD | 26,840 | $1.73 | $46.4K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Mar 4, 2026 | AWARD | 21,560 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Mar 4, 2026 | AWARD | 97,240 | $1.73 | $168.2K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Mar 4, 2026 | AWARD | 78,760 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Mar 4, 2026 | AWARD | 36,832 | $1.73 | $63.7K | Form 4 |
| Sumner Michael John | Chief Medical Officer | Mar 4, 2026 | AWARD | 29,608 | — | — | Form 4 |
| KIES PETER | CFO | Mar 4, 2026 | AWARD | 31,240 | $1.73 | $54.0K | Form 4 |
| KIES PETER | CFO | Mar 4, 2026 | AWARD | 25,520 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | OPTION EX. | 7,366 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | TAX W/H | 3,034 | $1.79 | $5.4K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | TAX W/H | 2,064 | $1.79 | $3.7K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | OPTION EX. | 7,366 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | OPTION EX. | 10,634 | — | — | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | TAX W/H | 6,294 | $1.79 | $11.3K | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | TAX W/H | 2,965 | $1.79 | $5.3K | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | OPTION EX. | 10,634 | — | — | Form 4 |
| KIES PETER | CFO | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | OPTION EX. | 28,401 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | TAX W/H | 13,657 | $1.79 | $24.4K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | OPTION EX. | 18,632 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | TAX W/H | 8,057 | $1.79 | $14.4K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | OPTION EX. | 28,401 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | Feb 26, 2026 | OPTION EX. | 18,632 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Feb 26, 2026 | OPTION EX. | 11,550 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Feb 26, 2026 | TAX W/H | 3,903 | $1.79 | $7.0K | Form 4 |
| Sumner Michael John | Chief Medical Officer | Feb 26, 2026 | OPTION EX. | 11,550 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Feb 26, 2026 | OPTION EX. | 5,010 | — | — | Form 4 |
| Weiner David B. | director | Feb 26, 2026 | OPTION EX. | 972 | — | — | Form 4 |
| Weiner David B. | director | Feb 26, 2026 | OPTION EX. | 972 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Jun 30, 2025 | OPTION EX. | 2,916 | — | — | Form 4 |
| Sumner Michael John | Chief Medical Officer | Jun 30, 2025 | OPTION EX. | 2,916 | — | — | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2025 | AWARD | 105,262 | $2.13 | $224.2K | Form 4 |
| Shea Jacqueline Elizabeth | director, officer: Chief Executive Officer | May 20, 2025 | AWARD | 84,888 | — | — | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2025 | AWARD | 22,419 | $2.13 | $47.8K | Form 4 |
| Humeau Laurent | Chief Scientific Officer | May 20, 2025 | AWARD | 18,081 | — | — | Form 4 |
| Zoth Lota S. | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| Zoth Lota S. | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| Miller Ann Calby | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| Miller Ann Calby | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| Shepard Jay | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| Shepard Jay | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| BENITO SIMON X | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| BENITO SIMON X | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| YARNO WENDY L | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| YARNO WENDY L | director | May 21, 2025 | OPTION EX. | 2,167 | — | — | Form 4 |
| KIES PETER | CFO | May 20, 2025 | AWARD | 31,950 | $2.13 | $68.1K | Form 4 |
| KIES PETER | CFO | May 20, 2025 | AWARD | 26,100 | — | — | Form 4 |
Congress & Senate Trades (1)
Chris JacobsHouse · NY27Sep 8, 2020